The Selective Use of Basiliximab Versus Thymoglobulin in Combination with Sirolimus for Cadaveric Renal Transplant Recipients at Low Risk Versus High Risk for Delayed Graft Function

Autor: Knight, Richard J., Kerman, Ronald H., Schoenberg, Linda, Podder, Hemangshu, Buren, Charles T. Van, Katz, Stephen, Kahan, Barry D.
Zdroj: Transplantation; September 2004, Vol. 78 Issue: 6 p904-910, 7p
Abstrakt: We previously reported that the use of basiliximab together with sirolimus permits a window of recovery from delayed graft function before the introduction of reduced-dose cyclosporine. The present study reviews our experience with the substitution of thymoglobulin for basiliximab as induction therapy for recipients at increased risk for early acute rejection episodes.
Databáze: Supplemental Index